Simian retrovirus receptor and neutralization mechanism by antibodies to the envelope glycoprotein

被引:6
作者
Anderson, DE [1 ]
Torres, JV [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA
关键词
D O I
10.1089/vim.1999.12.47
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type D simian retroviruses (SRV) cause an acquired immunodeficiency syndrome (AIDS) in monkeys. Results of infection with SRV range from complete recovery with absence of viremia to a viremic state, which produces AIDS-like symptoms and culminates in death. These varied outcomes render the interaction of the host and SRV an attractive model for the study of immunosuppressive retrovirus resulting in different pathologic consequences. We describe here the isolation and determination of the molecular weight of the receptor for SRV, We demonstrate that a cell receptor with the same molecular weight is bound by the envelope protein of all five serotypes of SRV, We also show that the receptor recognizes a region containing amino acids 142-167 of the envelope protein of SRV serotype 1 (SRV-1), In addition, we show that a different region of SRV serotype 2 (SRV-2) envelope protein containing amino acids 93-106, interacts with a cell receptor of identical molecular weight. Furthermore, polyclonal and monoclonal antibodies that are directed to envelope epitopes 142-167 of SRV-1 or to 93-106 of SRV-2, specifically neutralize only the respective viral serotype, Our results indicate that the neutralization of SRV infectivity by antibodies is achieved through blocking the interaction between the virus and its cell receptor.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 34 条
[1]   HYPERVARIABLE EPITOPE CONSTRUCTS AS A MEANS OF ACCOUNTING FOR EPITOPE VARIABILITY [J].
ANDERSON, DE ;
MALLEY, A ;
BENJAMINI, E ;
GARDNER, MB ;
TORRES, JV .
VACCINE, 1994, 12 (08) :736-740
[2]   ISOLATION OF A TYPE-D RETROVIRUS FROM B-CELL LYMPHOMAS OF A PATIENT WITH AIDS [J].
BOHANNON, RC ;
DONEHOWER, LA ;
FORD, RJ .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5663-5672
[3]  
BRYANT ML, 1986, JNCI-J NATL CANCER I, V77, P965
[4]  
FINE DL, 1975, J NATL CANCER I, V54, P651
[5]  
Gardner M. B., 1985, Advances in Viral Oncology, V5, P57
[6]   The history of simian AIDS [J].
Gardner, MB .
JOURNAL OF MEDICAL PRIMATOLOGY, 1996, 25 (03) :148-157
[7]   PCR AMPLIFICATION AND DNA-SEQUENCING OF SRV-2 FROM ARCHIVED TUMOR-TISSUES [J].
GRANT, RF ;
MALINAK, CJ ;
WU, H ;
SABO, A ;
TSAI, CC .
VIRUS RESEARCH, 1995, 36 (2-3) :187-200
[8]   CHARACTERIZATION OF INFECTIOUS TYPE-D RETROVIRUS FROM BABOONS [J].
GRANT, RF ;
WINDSOR, SK ;
MALINAK, CJ ;
BARTZ, CR ;
SABO, A ;
BENVENISTE, RE ;
TSAI, CC .
VIROLOGY, 1995, 207 (01) :292-296
[9]   INDUCTION OF SIMIAN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (SAIDS) WITH A MOLECULAR CLONE OF A TYPE-D SAIDS RETROVIRUS [J].
HEIDECKER, G ;
LERCHE, NW ;
LOWENSTINE, LJ ;
LACKNER, AA ;
OSBORN, KG ;
GARDNER, MB ;
MARX, PA .
JOURNAL OF VIROLOGY, 1987, 61 (10) :3066-3071
[10]   PROTECTION OF MACAQUES AGAINST SIMIAN AIDS BY IMMUNIZATION WITH A RECOMBINANT VACCINIA VIRUS EXPRESSING THE ENVELOPE GLYCOPROTEINS OF SIMIAN TYPE-D RETROVIRUS [J].
HU, SL ;
ZARLING, JM ;
CHINN, J ;
TRAVIS, BM ;
MORAN, PA ;
SIAS, J ;
KULLER, L ;
MORTON, WR ;
HEIDECKER, G ;
BENVENISTE, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7213-7217